Epithelial to mesenchymal transition in the liver field: the double face of Everolimus in vitro

BACKGROUND: Everolimus (EVE), a mammalian target of rapamycin inhibitor, has been proposed as liver transplant immunosuppressive drug, gaining wide interest also for the treatment of cancer. Although an appropriate tolerance, it may induce several adverse effects, such as fibro-interstitial pneumoni...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:BMC Gastroenterol
Hoofdauteurs: Masola, Valentina, Carraro, Amedeo, Zaza, Gianluigi, Bellin, Gloria, Montin, Umberto, Violi, Paola, Lupo, Antonio, Tedeschi, Umberto
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2015
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4570634/
https://ncbi.nlm.nih.gov/pubmed/26369804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-015-0347-6
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items